[Immunotherapy with low-dose subcutaneous interleukin-2 in metastatic renal carcinoma].
Lissoni P, Barni S, Tancini G, Andres M, Scardino E, Cardellini P, Frascaroli M, Ardizzoia A, Crispino S, Vicini D, et al.
Lissoni P, et al. Among authors: cardellini p.
Arch Ital Urol Androl. 1993 Apr;65(2):123-8.
Arch Ital Urol Androl. 1993.
PMID: 8330055
Clinical Trial.
Italian.